INS and thyroid cancer: In addition, metformin antagonized the growth-stimulating effects of insulin, inhibited clonal cell growth, reduced thyroid cancer spheroid formation and enhanced the antimitotic effects of chemotherapeutic agents (doxorubicin and cisplatin) on anaplastic thyroid cancer (ATC) cells [13, 74].